Published in Can J Infect Dis on March 01, 2004
Toxin B is essential for virulence of Clostridium difficile. Nature (2009) 5.49
The role of toxin A and toxin B in Clostridium difficile infection. Nature (2010) 5.32
Truncation in the tcdC region of the Clostridium difficile PathLoc of clinical isolates does not predict increased biological activity of Toxin B or Toxin A. BMC Infect Dis (2009) 1.10
A mixture of functionally oligoclonal humanized monoclonal antibodies that neutralize Clostridium difficile TcdA and TcdB with high levels of in vitro potency shows in vivo protection in a hamster infection model. Clin Vaccine Immunol (2013) 1.03
Persistence and toxin production by Clostridium difficile within human intestinal organoids result in disruption of epithelial paracellular barrier function. Infect Immun (2014) 1.01
Identification of an epithelial cell receptor responsible for Clostridium difficile TcdB-induced cytotoxicity. Proc Natl Acad Sci U S A (2015) 0.97
Toxin-mediated paracellular transport of antitoxin antibodies facilitates protection against Clostridium difficile infection. Infect Immun (2014) 0.91
Clostridium difficile: its disease and toxins. Clin Microbiol Rev (1988) 7.26
Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature (1995) 6.08
Effects of Clostridium difficile toxins given intragastrically to animals. Infect Immun (1985) 5.44
Comparison of two toxins produced by Clostridium difficile. Infect Immun (1981) 5.16
Biological activities of toxins A and B of Clostridium difficile. Infect Immun (1982) 4.62
Molecular characterization of the Clostridium difficile toxin A gene. Infect Immun (1990) 4.06
Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion. Microbiol Rev (1996) 3.46
Antibiotic-associated diarrhea. Clin Infect Dis (1992) 2.97
Large clostridial cytotoxins--a family of glycosyltransferases modifying small GTP-binding proteins. Trends Microbiol (1996) 2.85
Rho protein regulates tight junctions and perijunctional actin organization in polarized epithelia. Proc Natl Acad Sci U S A (1995) 2.70
Effects of the two toxins of Clostridium difficile in antibiotic-associated cecitis in hamsters. Infect Immun (1982) 2.65
Differential effects of Clostridium difficile toxins A and B on rabbit ileum. Gastroenterology (1987) 2.54
Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile. Infect Immun (1992) 2.49
Financial burden of hospital-acquired Clostridium difficile infection. J Hosp Infect (1996) 2.34
Clostridium difficile: clinical considerations. Rev Infect Dis (1990) 2.28
Epithelial properties of human colonic carcinoma cell line Caco-2: electrical parameters. Am J Physiol (1984) 2.01
Comparative sequence analysis of the Clostridium difficile toxins A and B. Mol Gen Genet (1992) 2.00
Purification and properties of Clostridium difficile cytotoxin B. J Biol Chem (1986) 1.97
Clostridium difficile infection associated with antineoplastic chemotherapy: a review. Clin Infect Dis (1993) 1.81
Serogroup F strains of Clostridium difficile produce toxin B but not toxin A. J Med Microbiol (1993) 1.78
Active and passive immunization to protect against antibiotic associated caecitis in hamsters. Dev Biol Stand (1983) 1.45
C. difficile toxin A increases intestinal permeability and induces Cl- secretion. Am J Physiol (1990) 1.37
HIV infection/AIDS in the United States during the 1990s. Clin Infect Dis (1993) 1.33
Localization of two epitopes recognized by monoclonal antibody PCG-4 on Clostridium difficile toxin A. Infect Immun (1992) 1.32
Cellular internalisation of Clostridium difficile toxin A. Microb Pathog (1987) 1.20
A comparative biochemical, pharmacological and immunological study of Clostridium novyi alpha-toxin, C. difficile toxin B and C. sordellii lethal toxin. Toxicon (1991) 1.10
Rapid death of infant rhesus monkeys injected with Clostridium difficile toxins A and B: physiologic and pathologic basis. J Pediatr (1984) 1.00
Purification of a functional receptor for Clostridium difficile toxin A from intestinal brush border membranes of infant hamsters. Clin Infect Dis (1993) 0.98
Control of nosocomial transmission of Clostridium difficile based on sporadic case surveillance. Am J Med (1991) 0.95
Sequencing and analysis of the gene encoding the alpha-toxin of Clostridium novyi proves its homology to toxins A and B of Clostridium difficile. Mol Gen Genet (1995) 0.93
Clostridium difficile: a pathogen of the nineties. Eur J Clin Microbiol Infect Dis (1998) 0.91
Morphological changes in adherent cells induced by Clostridium difficile toxins. Biochem Soc Trans (1991) 0.81
Identification of blood culture isolates directly from positive blood cultures by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry and a commercial extraction system: analysis of performance, cost, and turnaround time. J Clin Microbiol (2012) 1.59
Truncation in the tcdC region of the Clostridium difficile PathLoc of clinical isolates does not predict increased biological activity of Toxin B or Toxin A. BMC Infect Dis (2009) 1.10
Thermostable DNase is superior to tube coagulase for direct detection of Staphylococcus aureus in positive blood cultures. J Clin Microbiol (2007) 1.08
Reductions in workload and reporting time by use of methicillin-resistant Staphylococcus aureus screening with MRSASelect medium compared to mannitol-salt medium supplemented with oxacillin. J Clin Microbiol (2008) 0.95
ESBL genotypes in fluoroquinolone-resistant and fluoroquinolone-susceptible ESBL-producing Escherichia coli urinary isolates in Manitoba. Can J Infect Dis Med Microbiol (2007) 0.84
CHROMagar Orientation medium reduces urine culture workload. J Clin Microbiol (2013) 0.84
Detection of Clostridium difficile in retail ground meat products in Manitoba. Can J Infect Dis Med Microbiol (2012) 0.83
Multidrug-resistant North American pulsotype 2 Clostridium difficile was the predominant toxigenic hospital-acquired strain in the province of Manitoba, Canada, in 2006-2007. J Med Microbiol (2012) 0.80